(Q28370510)

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

The role of oxytocin and vasopressin in the initiation of preterm and term labour as well as primary dysmenorrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Vascular effects of [Arg8]vasopressin in the isolated perfused rat kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

[Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin-induced uterine contractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Innervation of the human uterine artery and contractile responses to neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Differences in vasomotor responses between main stem and smaller branches of the human uterine artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Oxytocin and vasopressin: distinct receptors in myometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Effect of oxytocin as a partial agonist at vasoconstrictor vasopressin receptors on the human isolated uterine artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Characterization of oxytocin actions in guinea-pig isolated uterine artery: the effect of pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Antagonists for the human oxytocin receptor: an in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Increases in oxygen tension evoke arteriolar constriction by inhibiting endothelial prostaglandin synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Receptor subtypes involved in relaxation and contraction by arginine vasopressin in canine isolated short posterior ciliary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Effect of oxytocin antagonists on the activation of human myometrium in vitro: atosiban prevents oxytocin-induced desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Effects of vasopressin and oxytocin on canine cerebral circulation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Characterization of vasopressin actions in isolated submucosal arterioles of the intestinal microcirculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9

Vasopressin and oxytocin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900351-9